Related by context. All words. (Click for frequent words.) 79 comprise Alnylam RNAi 71 activity dependent neurotrophic 69 activity dependent neuroprotective 69 intranasal vaccines derived 69 protein ADNP 69 Alfacell proprietary ribonuclease 68 factor ADNF 68 AAG geldanamycin analog 68 HuCAL PLATINUM ® CysDisplay 68 Receptors GPCRs 67 PDE4 modulators 67 proprietary polysaccharide 67 anionic backbone 67 DiLA2 67 patented NanoStat TM 67 Sangamo ZFP technology 67 Sangamo ZFP TF 67 Therapeutic Competitors Companies 66 CysDisplay R 66 TRANSDUR ® 66 DNA methyltransferase inhibitors 66 targeted diseased tissues 66 DURECT proprietary 66 Telik logo TELINTRA 66 novel RNAi therapeutics 66 ® famotidine 66 Bone Augmentation Material 66 ATRA IV 66 Pruvel ™ 66 ODT metoclopramide HCl PEPCID 66 peptidic compound 66 ALN PCS 66 By JAMAAL ABDUL 66 stable nucleic acid 66 TRANSDUR ™ 66 FORWARD LOOKING STATEMENTS INVOLVE 66 Initiates Phase II 66 Intravenous Human 65 platform HDL Mimetic 65 HCl PEPCID ® famotidine 65 polysaccharide polymer 65 include Altastaph TM 65 oral transdermal 65 VERIFICATION OF THE 65 Presents Preclinical Data 65 NASDAQ CRXL 65 도 65 sodium sulfate sodium chloride 65 developing Bicifadine serotonin 65 interferon beta 1a infertility 65 AtuRNAi 65 VentiRx Pharmaceuticals 65 DEBT AND IDENTITY 65 RON Notch 65 Solution XOPENEX HFA 65 DIURIL ® Chlorothiazide AZASAN 65 CYP#A# CYP#D# 65 rxRNA 65 rusalatide acetate 65 lipid particles SNALP 65 XL# anticancer compounds 65 TRADING HIGHER ON 1X 65 MDRNA proprietary 65 malignant infectious 65 UNCERTAINTIES OR OTHER 65 anti miRs antisense oligonucleotide 65 Locked Nucleic Acid 65 patented NanoStat ™ 65 PDGFR B 65 ZFP Therapeutics applications 65 Ovitrelle R Serostim 65 proprietary MSCRAMM ® 65 monocytogenes Listeria vaccines 65 proven DuraSite ® 64 Locteron combines 64 Pruvel TM 64 INVOLVE RISKS AND UNCERTAINTIES 64 tartrate Inhalation Aerosol BROVANA 64 UNCERTAINTIES AND OTHER FACTORS 64 Civacir TM Hepatitis C 64 NeoLipid R 64 Luveris R Ovidrel R 64 Staphylococcus aureus Immune Globulin 64 REDUCED DEMAND FOR 64 Locked Nucleic Acid LNA 64 GlycoPEGylated hemostasis compounds 64 inhibitor PPI 64 一个 的 64 liposomal delivery 64 virus AAV 64 polymer conjugate technology 64 benzoyl peroxide LIDEX R 64 tests miRview TM 64 Oral Suspension Oral Suspension 64 Micromet proprietary BiTE 64 Files IND 64 c Raf kinase 64 SMaRT ™ 64 HuCAL GOLD R 64 Oral Solution OSMOPREP 64 HDL Therapy 64 platinum chemotherapeutic 64 pralatrexate injection folate analogue 64 하는 64 WRX STi +# mins 64 naloxol derivative 64 5 HT6 64 includes iFinix RealTime 64 agonistic human 64 RISKS UNCERTAINTIES AND OTHER 64 ALN HPN 64 RELY UPON THIS 64 IS BEING MADE ONLY 64 Initiates Enrollment 64 molecular imaging radiopharmaceutical 64 Cardium Therapeutics TM 64 leading lipid nanoparticle 64 Kinase Inhibitor 64 Evo IX +# mins 64 utilizes InSite Vision 64 ABLYNX 63 R famotidine 63 Nventa proprietary CoVal 63 에 을 63 microRNA antagonists 63 Emergent marketed 63 taxane derivative 63 DG# compounds targeting 63 vapreotide acetate 63 SUCH FORWARD LOOKING STATEMENTS 63 他们 的 63 AVAILABLE BECAUSE THEY CONTAIN 63 TM Aganocide 63 CONTAINED IN THIS 63 commercializing anti infective 63 很多 63 的 中 63 TIME EXCEPT AS REQUIRED 63 WHICH MAY CAUSE 63 product platforms AZX# 63 R Saizen R 63 这一 63 candidates Azedra TM 63 DiLA 2 63 PROSPECTUS PROXY STATEMENT BECAUSE 63 Protein Kinase C 63 Targeting microRNAs 63 INACCURACIES IN THE DOW 63 topically applied SEPA 63 Inc. OTCBB ECTE 63 IS NOT INDICATIVE OF 63 Antigen Express comprise immunotherapeutics 63 By THERESA CAMPBELL 63 sapropterin dihydrochloride 63 THAT ARE SUBJECT TO 63 C2 S# +# mins 63 Veronate R 63 courant.co.uk 63 ANTICIPATES TARGETS GOALS PROJECTS 63 Factor Receptor 63 targets Galectin receptors 63 AVAX AC Vaccine 63 system vaporizes unformulated 63 Factor VIIa Factor VIII 63 NovaDel oral spray 63 RONDEL TM 63 OpenArray ® 63 brand ciclesonide HFA 63 CONTAIN FORWARD LOOKING STATEMENTS 63 因为 63 G Protein Coupled 63 siRNA binds 63 这些 63 INVESTORS AND SHAREHOLDERS ARE 63 lead molecular radiotherapeutic 63 RESULTS TO DIFFER 63 PEGylated anti 63 ABL inhibitor 63 Receives Orphan Drug Designation 63 MP4 molecule 63 MicroMacro TM Multi 63 delivery polymer matrix 63 5 HT3 antagonist 63 INFORMATION INCLUDING STATEMENTS RELATING 63 ACOOLIDGE@ENQUIRER.COM 63 THE FUTURES CHARTS 63 By MICHAEL FORTUNA 63 Novel Oral 63 novel VDA molecule 63 一些 63 已经 63 TO READ THE DEFINITIVE 63 oncolytic virus therapies 63 selective kinase inhibitor 63 * LW# * 63 OFFER TO PURCHASE LETTER 63 THEREON 63 targeting Inflammatory Bowel 63 REGULATORY APPROVAL PROCESS COMPETITIVE 63 może być niezwłocznie przeredagowana 63 READ THE DEFINITIVE 63 Completes Patient Enrollment 63 FOR REDEMPTION BY 63 OTHERWISE EXCEPT AS REQUIRED 63 一位 63 MATERIALLY DIFFERENT FROM THOSE 63 四 六级 63 Atripla combines 63 OR THE APPLICABLE 62 TO BE SATISFIED INCLUDE 62 BY EILEEN MOZINSKI 62 RONDEL ™ 62 including thyroiditis RA 62 THESE CONDITIONS NOT 62 PRICE GREAT DISCOUNT FREE 62 THAT COULD CAUSE ACTUAL 62 AND UNKNOWN COULD CAUSE 62 INVESTORS ARE URGED TO 62 IMiDs R 62 novel topoisomerase 62 MasterCard inControl ® 62 认为 62 Gonal f R follitropin 62 Potassium Chloride Sodium Ascorbate 62 IMPORTANT FACTORS THAT COULD 62 Reports Preclinical Data 62 MATERIALLY FROM ANY FUTURE 62 novel emulsion formulation 62 UNCERTAINTIES OR OTHER FACTORS 62 inflammatory PDE 62 acid phosphatase PAP 62 Epivir HBV R 62 KNOWN AND UNKNOWN RISKS 62 PROCTOCORT R 62 大学 英语 62 mGluR5 negative 62 AWAY FROM WINDOWS 62 XmAb ® 62 MATERIALLY FROM THOSE EXPRESSED 62 CONTAINS FORWARD LOOKING STATEMENTS 62 4 PDE4 enzyme 62 NASDAQ MNKD focuses 62 BY JAMES MCNAIR 62 BY COPYRIGHT LAW 62 Oligonucleotide 62 novel synthetic PEGylated 62 palonosetron hydrochloride Injection Dacogen 62 DiLA2 Platform 62 Kosan dependence 62 USP Tablets PEPCID 62 THE REPORTING 62 ® SHOWTIME WOMEN 62 AtuPLEX 62 TO POTENTIALLY REBOUND AFTER 62 folate analogue metabolic 62 attach auristatin 62 VERANTWORTLICH 62 那些 62 Dyax logo 62 SUBSEQUENTLY ACHIEVED BY 62 PINNACLEDIGEST.COM S PAST PERFORMANCE 62 AFFECT MICROSEMI 'S 62 treat refractory angina 62 triciribine phosphate monohydrate 62 READ THE PROXY 62 cancer immunotherapeutics 62 endosomal release 62 SMARTREND DETECTS POTENTIAL BREAK 62 EXPOSED SKIN 62 STATEMENT WHEN IT BECOMES 62 ALN TTR 62 HCV NS3 protease 62 AND CONDITIONS OF 62 MSCRAMM ® 62 By CARL MARIO 62 specific lectin receptors 62 novel proprietary KL4 62 Pain Neutralizer holds 62 alpha folate receptor 62 SHALL NOT CONSTITUTE AN 62 flow cytometry morphology 62 OTHER THAN PURELY HISTORICAL 62 selective adhesion molecule 62 TO BE ACCURATE 62 BE HELD RESPONSIBLE FOR 62 并 62 Hsp# Inhibitor 62 DATA ARE FORWARD 62 proprietary transdermal 62 enhanced skin permeation 62 ARE NOT INTENDED TO 62 TO THE COMPANY 62 oral ferric iron 62 CERTAIN RISKS AND UNCERTAINTIES 62 ARTICLES SOLELY FOR YOUR 62 BECAUSE THEY WILL CONTAIN 62 MOVE IN TANDEM 62 所有 的 62 dihydrochloride Phase 3 62 内容 62 这 是 62 Cytogen marketed 62 UK NO.1 LIMITED 62 CAREFULLY READ THESE MATERIALS 62 它们 62 OR ACHIEVEMENTS OF 62 secretory phospholipase A2 62 CORDURA ® CORFREE ® 62 Darinaparsin Zinapar TM 62 TIMES REPUBLICAN 62 IMPLY THAT OPTION PRICES 62 ECONOMIC EVALUATIONS AND 62 2hours #mins #.#secs M 62 orally administered inhibitor 62 Zorbtive TM 62 ITS ENTIRETY BECAUSE 62 pan histone deacetylase 62 spytak@republicanherald.com 62 acetonide FA 62 PAST RESULTS 62 EXPRESSED OR IMPLIED 62 SILVER AND ITS 62 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 62 Nasdaq XTLB 62 metabolic disorders Saizen R 62 MATERIALS BECAUSE THEY CONTAIN 62 DECISION WITH RESPECT TO 62 PNP inhibitor 62 investigational humanized monoclonal antibody 62 BE DELAYS OMISSIONS OR 62 Alcortin TM 62 ARE ONLY PREDICTIONS 62 product candidate Lpathomab 62 includes TOLAMBA TM 62 OR INVESTMENT DECISION 62 NicVAX TM 62 short interfering RNA 62 MATERIALS AS THEY BECOME 62 对 的 62 将 的 62 THEY CONTAIN IMPORTANT INFORMATION 62 MTP inhibitor 62 AMONG THE FACTORS THAT 62 ARRY # 62 DIURIL R 62 和 的 62 REGULATORY AUTHORITY HAS APPROVED 62 PURSUANT TO THE 62 TO BUY ANY SECURITIES 62 这 62 Personalized Immunotherapy 62 OF AGRIUM AND 62 THE TIME ALLOWED 62 REPORTS FILED WITH 62 REPUBLICAN AMERICAN 62 ACTUAL RESULTS TO DIFFER 61 STOCKHOLDERS ARE URGED TO 61 INDIVIDUALLY AND 61 dihydrochloride Tablets 61 antiangiogenesis therapies 61 NATURE OF THE PROCEEDING 61 antagomirs 61 Initiates Dosing 61 'S FUTURE PLANS 61 MUST BE PAID FOR 61 Solazed TM 61 complementary dermatology 61 AVEO Pharmaceuticals NASDAQ 61 targeted radiotherapeutic 61 ® LYCRA ® 61 Through Glycoscience R 61 technology Parthenogenesis 61 HuCAL R 61 - EnWriters Joshua Freed 61 FACTORS WHICH MAY CAUSE 61 ARE STRONGLY ADVISED TO 61 Presents Preclinical 61 WHICH ARE NOT PURELY 61 THE ACTUAL RESULTS 61 PRESS RELEASE ARE FORWARD 61 ENTIRETY BECAUSE THEY CONTAIN 61 OR ACHIEVEMENTS EXPRESSED OR 61 Selective Electrochemical Tumor Ablation 61 方面 61 By Mannix Porterfield 61 EXPLANATION OF THE 61 phenylketonuria PKU developed 61 IS PROTECTED BY 61 PURCHASE LETTER OF TRANSMITTAL 61 INCLUDE CHANGES IN 61 mGluR4 mGluR2 mGluR5 61 THE DEFINITIVE JOINT PROXY 61 HCV protease 61 ® sodium phosphate 61 VARIOUS TERMS OF 61 HYPOTHETICAL PERFORMANCE RESULTS 61 BEFORE ANY PACKING 61 humanized monoclonal 61 EXCHANGE OR 61 targeting CD# 61 ELADUR ™ 61 poly ADP ribose polymerase 61 LOSS AND MAY 61 Evo +# mins 61 ANY RESPONSIBILITY FOR ANY 61 By Janice Hoppe 61 THE TIME PROVIDED 61 ANY FUTURE RESULTS PERFORMANCE 61 AND COMPRISES CANOPY PORCH 61 protein tyrosine phosphatase 1B 61 Panzem R 61 IS NOT AFFECTED BY 61 THE OFFER DOCUMENTS 61 Synavive ™ 61 isoform selective 61 cortisol synthesis 61 WE URGE INVESTORS 61 M2 subunit 61 MKC# MKC# PP 61 oral dihydropyrimidine dehydrogenase DPD 61 IT WILL CONTAIN 61 THE PROPOSED TRANSACTION 61 SUN CHRONICLE STAFF 61 世界 上 61 AND RELATED LETTER OF 61 MANAGEMENT 'S CURRENT BELIEFS 61 fibrin derived 61 pentadentate logo R 61 WITH FUTURES PRICES 61 R MSCRAMM 61 Selzentry Celsentri 61 自己 的 61 AREAS AFFECTED 61 accumulate preferentially 61 AND ACTUAL RESULTS 61 Gonal f R 61 CCR9 antagonist 61 MADE BASED UPON 61 AND CONDITIONS TO 61 Crofelemer budesonide foam 61 MATERIALLY DIFFERENT FROM 61 targeted antifolate 61 INABILITY TO SATISFY DEBT 61 Nicotine Conjugate Vaccine 61 着 61 USP Tablets VISICOL ® 61 研究 61 需要 61 BY SUCH STATEMENTS 61 OF AN OFFER 61 ENQUIRER STAFF WRITER 61 MATERIALLY FROM CURRENT EXPECTATIONS 61 THIS IS NEITHER 61 oral isoform selective HDAC 61 fibrosis IPF 61 placement privé par 61 robust interlibrary loan 61 INFORMATION CONTAINED IN 61 % pramoxine HCl 61 LOOKING STATEMENTS CAN BE 61 NS5b 61 potently inhibit 61 developing TB4 61 BY REBECCA GOODMAN 61 IMPLIED BY 61 BY SUSAN TOMPOR FREE 61 CHEAP ONLINE PHARMACY LOW 61 XmAb TM 61 RISKS COULD CAUSE ACTUAL 61 MOTHER WOULD 'VE SAID 61 benzoic acid hyoscyamine sulfate 61 Affilin ® 61 RESULTS PERFORMANCE OR ACHIEVEMENTS 61 studies anatomic pathology 61 PORxin TM 61 BY DUSTIN DOW 61 Cyclosert TM 61 COMUNICADO DE 61 tyrosine kinase receptor 61 发现 的 61 INVOLVE KNOWN AND UNKNOWN 61 mTOR mammalian target 61 R roscovitine CDK cyclin 61 Aganocide 61 novel orally inhaled 61 monobasic monohydrate USP 61 THE MERGER CAREFULLY AND 61 Inc. AMEX YMI 61 un redattore 61 Inc. www.micromet inc.com 61 THEY WILL CONTAIN IMPORTANT 61 Intermezzo ® zolpidem tartrate 61 AN# topical anti 61 MATTERS DISCUSSED IN 61 unten stehenden Link 61 AT ANY PARTICULAR 61 THEY BECOME AVAILABLE BECAUSE 61 AND OTHER RISKS AND 61 FORWARD LOOKING STATEMENTS INHERENTLY 61 TRACON Pharmaceuticals 61 Captisol ® 61 auf Ihrer Webseite ein 61 ACTUAL RESULTS PERFORMANCE 61 THE AMERICANS HAVE 61 Marcus Gronholm BP 61 UltiMAb TM 61 By GLENDA SANDERS 61 TO MATERIALLY DIFFER 61 BIDDER AS ACKNOWLEDGED BY 61 monoclonal antibody IgG1 Mab 61 AND USE CAUTION 61 GVAX ® 61 CHEAP ONLINE PHARMACY BEST 61 5 lipoxygenase activating 61 siRNA molecules AtuRNAi 61 AUCTIONEERS UNAUTHORIZED USE 61 AND INFORMATION INCLUDE 61 CONTENT PROVIDERS OR LICENSORS 61 biocompatibility capabilities 61 STATEMENTS WITHIN THE MEANING 61 phenylalanine ammonia lyase 61 ACTUAL RESULTS LEVEL OF 61 方面 的 61 OR ASSIGNS MAY BE 61 topical gel formulation 61 AND TO REOFFER 61 ACTIVITIES CONCLUSIONS OF 61 Serostim R 61 2 inhibitor CYT# 61 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 61 OFFER TO PURCHASE 61 HAVE BEEN DISTRIBUTED TO 61 Announces Poster Presentations 61 world safest multivalent 61 ARE MADE AS 61 cell differentiation angiogenesis 61 erlotinib Tarceva R 61 THE COMPANY WHO TAKES 61 non porcine pancreatic 61 CuperTek Cycle Computing Dataline 61 ROADS AND LIMITED VISIBILITIES 61 tests miRview ™ 61 OF CURRENT EXPLORATION 61 methylnaltrexone bromide 61 报道 说 61 不是 61 Sodium Sulfate Sodium Chloride 61 SENOMYX 61 BLIZZARD WARNING MEANS SEVERE 61 IS FOR INFORMATIONAL 61 LOOKING STATEMENTS WHICH INVOLVE 61 novel histone deacetylase 61 NASDAQ PPHM clinical 61 OMISSIONS OR INACCURACIES IN 61 Ovidrel R Ovitrelle R 61 INCLUDING DETAILED RISK FACTORS 61 BAG# BAG# 61 INVESTORS ARE CAUTIONED NOT 61 CF ARE URGED 61 Mylan Receives Approval 61 PROXY STATEMENT WHEN 61 THE FOREGOING IN 61 include PLX IBD 61 MKC# MT 61 'S STOCKHOLDERS ARE 61 AKIP ™ 61 treat male hypogonadism 61 CHARACTER INTERNALLY WITH EXPOSED 61 人们 61 pan HDAC inhibitor 60 proprietary BiTE ® 60 MAY CAUSE THE 60 他们 60 INFORMATION ABOUT THE PROPOSED 60 lintuzumab SGN 60 jfr 60 THOSE STATEMENTS 60 MetaBase TM represents 60 IN AGRICULTURAL PRODUCTION AND 60 einem firmeneigenen oxo biologisch 60 Submits NDA 60 prostate cancer antigen prostatic 60 2 methoxyestradiol 60 HSP# inhibitor 60 Completes Enrollment 60 MATERIALLY FROM THOSE CONTAINED 60 NTDDS 60 AAMORINI@COMMUNITYPRESS.COM 60 DOWNGRADE ALERT WATCH FOR 60 dermal tissues keratinocyte migration 60 Begins Dosing 60 Xcytrin R 60 SEATTLEPI.COM STAFF 60 SUCH INFORMATION 60 BCG refractory carcinoma 60 positive allosteric modulator 60 #.#secs P 60 Inc. Nasdaq IMGN 60 novel L DOS# 60 CD# CEA 60 Inc. Nasdaq ALNY 60 PRESENTED AT 60 Zemiva TM Trofex TM 60 biochemical profiling 60 AP Photo BAG# 60 BNA THE METEOROLOGY 60 WMDT #/#/# [001] 60 IN THIS PROFILE 60 Cream Hydrocortisone Cream USP 60 Jari Ketomaa Subaru Impreza 60 NOT BE SUITABLE FOR 60 WINTER WEATHER CONDITIONS ARE 60 HISTORICAL INFORMATION PRESENTED HEREIN 60 DESCRIPTIONS ARE OUR OPINIONS 60 는 의 60 BY MATTHEW VAN 60 HER2 HER2 60 PLEASE READ THESE TERMS 60 humanized anti 60 AND OPTIONS INVOLVES 60 inhibit oxidative stress 60 AND RELATED MATERIALS BECAUSE 60 Proc Am Soc 60 MATERIALLY FROM THESE FORWARD 60 DOES SEEKING ALPHA ASSUME 60 siRNA delivery 60 Nasdaq MNKD focuses 60 KL4 Surfactant 60 FORWARD LOOKING TERMINOLOGY SUCH 60 Enhanze TM Technology 60 PRN FDA Approves 60 LARGE CAP FUND SHOULD 60 THE ELECTRONIC VERSION 60 1hour #mins #.#secs M 60 Preclinical studies suggest 60 developing ACAPODENE 60 REJECT ANY BID 60 PATENT FOR 60 * olmesartan medoxomil 60 jrr 60 PRIOR TO MAKING ANY 60 NOT PROPERTY USED 60 BASED LARGELY ON 60 systemic RNAi 60 Antisense Oligonucleotides 60 telomerase inhibitor drug 60 BE ANY SALE 60 Initiates Clinical Trial 60 而 60 RISK FACTORS DISCLOSED IN 60 REGISTRATION STATEMENT BECAUSE THEY 60 ArQule Kinase Inhibitor Platform 60 hyaluronidase enzyme 60 CONSTITUTE AN OFFER 60 CHANGES IN PROJECT PARAMETERS 60 OTHERWISE REPRODUCED REPACKAGED FURTHER 60 FOUND IN OUR PERIODIC 60 6 sulfatase 60 - bw comment Inner 60 POLYSHIELD ® POLYCLEAR ® 60 siRNA therapeutic 60 TO OBTAIN INSURANCE 60 ITS GROWTH STRATEGIES AS 60 delivered RNAi therapeutic 60 Namenda Memantine HCl 60 Bruton tyrosine kinase 60 ALLEIN DAS BERICHTENDE UNTERNEHMEN 60 PEGylated Fab fragment 60 OUR FEATURED COMPANIES ARE 60 AND DISCLAIMERS BY 60 CONDENSED PARAPHRASE OF 60 Aptamers 60 apoptosis proteins 60 fatty acid amide hydrolase 60 ZFN TM 60 Bonjour l' accès à 60 WHILE THE COMPANY 60 OTHERWISE INCLUDING BUT NOT 60 Janus kinase 60 PROfusion 60 IAP inhibitor 60 OR IMPLIED STATUTORY OR 60 IMiDs ® compound 60 MicroMacro ™ Multi 60 somatropin Kuvan R 60 POTTER AUCTIONS OR 60 memantine HCl 60 THE AUCTIONEER RESERVES 60 ZFP Therapeutics 60 CYT# potent vascular disrupting 60 RNAi therapeutic targeting 60 ALL ITEMS ARE SOLD 60 REPRESENTATION OR WARRANTY EXPRESS 60 peripherally acting 60 HYVISC ® treatment 60 WORDS AND PHRASES 60 By Sheena Delazio 60 low toxicity bioscience 60 l' entremise d' 60 candidates Azedra 60 ARE REASONABLE THERE CAN 60 OF WILLIAM JENACK 60 MT# MEDI 60 SUBSTANTIAL RISK OF 60 SIDE EFFECTS CHEAP ONLINE 60 AGAINST YOU 60 XP# XP# 60 TFN.newsdesk @ thomson.com jjo 60 Vidaza ® 60 vinorelbine tartrate 60 其中 60 PEG PAL PEGylated recombinant 60 mark eOn 60 OFFERED FOR SALE 60 'S ® DOLMIO 60 software rapidly identif 60 Company TAIFUN R 60 active AKT inhibitor 60 vivo fluorescence imaging 60 Citroen Xsara WRC +# 60 THE ISSUER AND ITS 60 Adagen ® 60 por las propias empresas 60 THE TENDER OFFER STATEMENT 60 DO THEIR OWN DUE 60 Die ZDNet Redaktion 60 WORDS SUCH AS 60 oral isotype selective HDAC 60 investigational oral inhibitor 60 REASONABLE BY 60 IT BECOMES AVAILABLE BECAUSE 60 PURPOSES ONLY AND 60 AppStream Array Networks 60 AND CONSENT SOLICITATION 60 subsidiaries visit http:/www.apricusbio.com 60 HGS ETR1 mapatumumab 60 certain protein tyrosine 60 Sports Editor mlinnell@minotdailynews.com 60 Vascular Disrupting Agent 60 please visit http:/www.vandapharma.com 60 REPORTS FILED FROM 60 peptibody 60 ARE ADVISED TO READ 60 Alnylam #x# 60 humanized therapeutic 60 Las informaciones del apartado 60 thrombin component 60 viagra canada best 60 vivo electroporation 60 SECURITY HOLDERS ARE ADVISED 60 ENTRANCE HALL CLOAKROOM WC 60 JAK2 Inhibitor 60 AND WHILE EFFORTS 60 CYP#A# isoenzyme 60 IMiD 60 Agonist MABA program 60 SinuNase ™ 60 TÎ ² 4 60 Nucleic Acid Detection Immunoassay 60 small molecule defensin 60 5 HT2A serotonin 60 THOSE ANTICIPATED IN 60 rHuPH# recombinant human 60 OF ORIGINALITY ACCURACY TIMELINESS 60 REGARDING THE TENDER OFFER 60 Initiate Clinical Trial 60 REPRESENTS THE EXPECTATIONS 60 INVESTORS SHOULD READ 60 including HGF ErbB3 60 PIG VIRUS THEY SHOULD 60 Recombinant Human 60 oral proteasome inhibitor 60 BAXTER INTERNATIONAL 60 A3 adenosine receptor 60 addressing idiopathic pulmonary 60 Upregulation 60 LONDON FOG R MOSSIMO 60 pathophysiological effects 60 small molecule glucokinase 60 oral prodrug 60 OFFER TO SELL OR 60 substitute generica 60 RELATING TO THE COMPANY 60 OR LIABLE 60 cetuximab Erbitux R 60 anti infective treatments 60 Unigene nasal calcitonin 60 diagnostic molecular imaging 60 BY JOE PALLADINO 60 MT#/MEDI-# 60 AND EXECUTIVE OFFICERS 60 TRANSCONTINENTAL MEDIA 60 RAS MAPK pathway 60 PDX pralatrexate 60 LESS THAN FIVE UNITS 60 考试 60 ARE ABANDONED 60 proteomics bioinformatics 60 Oral Solution VISICOL 60 Group SmartBill ® 60 ALSO CALLED 60 proprietary PEGylation 60 WEB SITE OR 60 Sei un appassionato o 60 IMiDs ® 60 OR USE OF 60 OTCBB PYTO 60 markets Testim ® 59 ENQUIRER CONTRIBUTOR 59 lht 59 HCV polymerase 59 MEDAREX 59 tsm 59 Hacker ID IMsecure 59 MCSP respectively 59 TELINTRA R 59 patented Bioral 59 Serostim ® 59 oral Hsp# inhibitor 59 THE GERMAN SECURITIES 59 sodium phosphate monobasic monohydrate 59 Company NASDAQ OMRI 59 peptide peptide mimetic 59 AND TO REMAIN 59 biomimetics non 59 BIDDING AT THIS AUCTION 59 SRUSSELL@ENQUIRER.COM 59 primary GeckoSavants 59 THE PROXY STATEMENT BECAUSE 59 INVESTORS AND STOCKHOLDERS ARE 59 candidate deforolimus 59 任何 59 IN BAKERS FOOTWEAR 'S 59 mda 7 59 JAK1 59 做 59 CD4 monoclonal antibody 59 THE COMPANY 'S PERIODIC 59 BY DAVID LINTON 59 anti botulism antibody 59 Vaccine Adjuvant 59 THR beta agonist 59 SUBJECT TO SIGNIFICANT 59 BY JIM HAND 59 BY JOHN ECKBERG 59 Targeted Chemotherapy 59 但 59 Azathioprine Tablets USP 59 Trubion proprietary 59 Announces Immediate Availability 59 Systemic Delivery 59 IS INTENDED FOR DISTRIBUTION 59 ARE MADE TO PROVIDE 59 allosteric modulator NAM 59 developing Zerenex ferric 59 Ariba Sourcing Ariba Spend 59 NEWS TONIGHT NDTV 59 Aradigm Logo 59 RNA interference RNAi therapeutics 59 class anticancer quinolone 59 Isis# where 59 SECURITIES COMMISSION OR OTHER 59 Restoraderm 59 BEAMS STONE AND WOODWORK 59 Chlorothiazide AZASAN R 59 答案 59 OR DISAPPROVED THE 59 THE AUCTIONEER 59 INVESTMENT OR OTHER DECISIONS 59 personalized cellular immunotherapy 59 products MKC# PP 59 MasterCard inControl ™ 59 abnormal p# 59 FUNDING AS WELL AS 59 Multi Mix PICO 59 novel orally administered 59 DepoCyt ® Abelcet ® 59 Ad5FGF 4 59 motexafin gadolinium Injection 59 GelVac TM 59 Zemiva TM 59 BY APPLICABLE LAW 59 BiTE ® 59 LUCK Happy Birthday 59 AUTHORITIES SUCH AS 59 HAS BEEN PREPARED BY 59 THE SOLICITATION OF 59 AS THEY WILL CONTAIN 59 lexidronam injection PROSTASCINT 59 #/#/# MOODY 'S [001] 59 Liposomal 59 TMC xtra 59 CAPE FEAR COMMUNITY COLLEGE 59 RELATING TO THE PARTICIPANTS 59 MBRX 59 histone deacetylase HDAC 59 Tumor necrosis factor 59 DIFICID ™ 59 Planetwide Media My 59 LOCAL AND MUNICIPAL 59 Rosetta Genomics Nasdaq ROSG 59 electrolytically generated source 59 INFORMATION INCLUDING THE 59 BUSINESS ECONOMIC COMPETITIVE 59 topical non steroidal 59 includes T1 E1 59 Bavarian Nordic patented 59 hyaluronic acid DYNACIN R 59 Eg5 kinesin spindle 59 Akt pathway associated 59 INFORMATION RELATING TO 59 THE COMPANY INCLUDE BUT 59 ONCE AVAILABLE 59 BELIEFS PLANS EXPECTATIONS OR 59 Kevin Klombies Senior 59 MATERIALLY FROM THE FUTURE 59 B lymphocyte stimulator 59 HAS WRITTEN 59 ARE NOT PROPERTY USED 59 By SABINA DANA 59 mg Suppository Hydrocortisone Acetate 59 RNAi Therapeutics 59 R ROYAL VELVET 59 BROWN EYE SHUT 59 RAF kinase VEGFR 59 FOLOTYN ® 59 Exherin 59 AVEO integrates proprietary 59 MATERIALLY FROM THOSE 59 OTC BB PVCT 59 PARI Pharma 59 THE SEC CAREFULLY 59 Inc. Nasdaq OXGN 59 AND WILL CONTAIN 59 highly selective inhibitor 59 THEREFORE ACTUAL RESULTS MAY 59 ALTROPANE R 59 Janus Kinase 59 ACTIQ ® 59 DITCH OR OTHER 59 LAW IS NOT 59 THE INFORMATION FOUND 59 synthetic analogs 59 LAW INCLUDING BUT NOT 59 PUBLIC WEBSITE WWW.FITCHRATINGS.COM 59 NOT SUITABLE INVESTMENTS 59 Hos2 59 #HT# 59 NEWS RELEASE CONSTITUTE FORWARD 59 Fleximer 59 triggers apoptosis programmed 59 Oracea TM 59 TRANSCRIPTION THERE MAY BE 59 AzaSite ISV 59 Dave van Ginhoven 59 REPRONEX ® menotropins 59 selectin antagonist 59 recombinant fusion 59 MAY BE COPIED OR 59 bevacizumab Avastin R 59 accessories autologous 59 Cobalamin TM mediated 59 programs visit http:/www.bionovo.com 59 WEATHER OFFICE 59 % POTENTIAL UPSIDE 59 ANY FORWARD LOOKING STATEMENTS 59 cardiometabolic diseases Glucophage 59 Soliris eculizumab 59 ARE NOT LIMITED 59 Vitamin D analogue 59 kidney urologic 59 Phase 2b Clinical Trial 59 ITS CONTENTS 59 selective antagonist 59 Declare Monthly Distributions 59 Epivir R 59 Homspera TM 59 JMCKINNEY@ENQUIRER.COM 59 Euronext Paris Code Isin 59 includes investigational compounds 59 candidate Lovaxin C 59 INCLUDING WITHOUT LIMITATION 59 WAS PREPARED BY KINBAURI 59 ® EBLY ® MASTERFOODS 59 elemental boron 59 BroadSoft BroadWorks ® 59 THE BASIC MATERIALS 59 SX4 WRC +# mins 59 Atridox R Atrisorb 59 Omacetaxine 59 THE PROXY SOLICITATION 59 proprietary BiTE antibody 59 ENL recurrence 59 SNALP 59 THE COMPANY ARE INHERENTLY 59 sulfonylhydrazine class 59 Tekmira SNALP stable 59 SEVERAL INCHES OF 59 Pentad TM